Formulation of parenteral microemulsion containing itraconazole

Archives of Pharmacal Research

Volumn 30, Issue 1, 2007, Pages 114-123

  Rhee, Yun Seok ^a   Park, Chun Woong ^a   Nam, Tae Young ^a   Shin, Yoon Sub ^a   Chi, Sang Cheol ^a   Park, Eun Seok ^a  

^a Sungkyunkwan University   (South Korea)

Author keywords

Itraconazole; Microemulsion; Parenteral

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN; ALCOHOL; ANTIFUNGAL AGENT; BENZYL ALCOHOL; BETA CYCLODEXTRIN DERIVATIVE; CASTOR OIL; DRUG DERIVATIVE; EXCIPIENT; HYDROXYITRACONAZOLE; ITRACONAZOLE; MACROGOL DERIVATIVE; RICINOMACROGOL; SOLVENT; SURFACTANT; TRIACYLGLYCEROL; WATER;

ANIMAL; ARTICLE; BLOOD; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECT; EMULSION; HEMOLYSIS; INTRAVENOUS DRUG ADMINISTRATION; MALE; PARTICLE SIZE; RAT; SOLUBILITY; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIFUNGAL AGENTS; BENZYL ALCOHOL; BETA-CYCLODEXTRINS; CASTOR OIL; CHEMISTRY, PHARMACEUTICAL; EMULSIONS; ETHANOL; EXCIPIENTS; HEMOLYSIS; INJECTIONS, INTRAVENOUS; ITRACONAZOLE; MALE; PARTICLE SIZE; POLYETHYLENE GLYCOLS; RATS; RATS, SPRAGUE-DAWLEY; SOLUBILITY; SOLVENTS; SURFACE-ACTIVE AGENTS; TRIGLYCERIDES; WATER;

EID: 33846846202     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02977787     Document Type: Article

References (39)

1. Anaissie, E., Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review. Clin. Infect. Dis., 14(Suppl 1), S43-53 (1992).
2. Bodey, G. P., Azole antifungal agents. Clin. Infect. Dis., 14 (Suppl 1), S161-169 (1992).
3. Bradford, C. R., Prentice, A. G., Warnock, D. W., and Copplestone, J. A., Comparison of the multiple dose pharmacokinetics of two formulations of itraconazole during remission induction for acute myeloblastic leukaemia. J. Antimicrob. Chemother., 28, 555-560 (1991).
4. Cauwenbergh, G., De Doncker, P., Stoops, K., De Dier, A. M., Goyvaerts, H., and Schuermans, V., Itraconazole in the treatment of human mycoses: review of three years of clinical experience. Rev. Infect. Dis., 9(Suppl 1), S146-152 (1987).
5. Como, J. A. and Dismukes, W. E., Oral azole drugs as systemic antifungal therapy. N. Engl. J. Med., 330, 263-272 (1994).
6. De Beule, K., De Doncker, P., Cauwenbergh, G., Koster, M., Legendre, R., Blatchford, N., Daunas, J., and Chwetzoff, E., The treatment of aspergillosis and aspergilloma with itraconazole, clinical results of an open international study (1982-1987). Mycoses, 31, 476-485 (1988).
7. Denning, D. W. and Stevens, D. A., Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Rev. Infect. Dis., 12, 1147-1201 (1990).
8. Dupont, B., Itraconazole therapy in aspergillosis: study in 49 patients. J. Am. Acad. Dermatol., 23, 607-614 (1990).
9. Floyd, A. G. and Jain, S., Injectable emulsions and suspensions. Pharmaceutical dosage forms: disperse system. Marcel Dekker, Vol. 2, pp. 261-318 (1996).
10. Floyd, A. G., Top ten considerations in the development of parenteral emulsions. Pham. Sci. Technolo. Today, 2, 134-143 (1999).
11. Fu, R. C., Lidgate, D. M., Whatley, J. L., and Mccullough, T., The biocompatibility of parenteral vehicles-in vitro/in vivo screening comparison and the effect of excipients on hemolysis. J. Parenter. Sci. Technol., 41, 164-168 (1987).
12. Gasco, M. R., Patarino, F., and Lattanzi, F., Long-acting delivery systems for peptides: reduced plasma testosterone levels in male rats after a single injection. Int. J. Pharm., 62, 119-123 (1990).
13. Grant, S. M. and Clissold, S. P., Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses. Drugs, 37, 310-344 (1989).
14. Hallett, F. R., Craig, T., Marsh, J., and Nickel, B., Particle size analysis: number distributions by dynamic light scattering. Can. J. Spectrosc., 34, 63-70 (1989).
15. Heykants, J., Van Peer, A., Van de Velde, V., Van Rooy, P., Meuldermans, W., Lavrijsen, K., Woestenborghs, R., and Cauwenbergh, G., The clinical pharmacokinetics of itraconazole: an overview. Mycoses, 32, 67-87 (1989).
16. Hwang, S. R., Lim, S. J., Park, J. S., and Kim, C. K., Phospholipid-based microemulsion formulation of all-trans-retinoic acid for parenteral administration. Int. J. Pharm., 276, 175-183 (2004).
17. Jumaa, M., Kleinebudde, P., and Muller, B. W., Mixture experiments with the oil phase of parenteral emulsions. Eur. J. Pharm. Biopharm., 46, 161-167 (1998).
18. Kim, K. H., Rhee, Y. S., Bae, J. H., Chi, S. C., and Park, E. S., Improvement of dissolution rate of poorly water soluble drug using self-microemulsifying drug delivery system. J. Kor. Pharm. Sci., 29, 37-45 (1999).
19. Kipp, J. E., The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs. Int. J. Pharm., 284, 109-122 (2004).
20. Krzyzaniak, J. F., Raymond, D. M., and Yalkowsky, S. H., Lysis of human red blood cells 2: effect of contact time on cosolvent induced hemolysis. Int. J. Pharm., 152, 193-200 (1997).
21. Miyake, K., Irie, T., Arima, H., Hirayama, F., Uekama, K., Hirano, M., and Okamaoto, Y., Characterization of itraconazole/2-hydroxypropyl-beta- cyclodextrin inclusion complex in aqueous propylene glycol solution. Int. J. Pharm., 179, 237-245 (1999).
22. Moreno, M. A., Ballesteros, M. P., and Frutos, P., Lecithin-based oil-in-water microemulsions for parenteral use: pseudoternary phase diagrams, characterization and toxicity studies. J. Pharm. Sci., 92, 1428-1437 (2003).
23. Park, K. M. and Kim, C. K., Preparation and evaluation of flurbiprofen-loaded microemulsion for parenteral delivery. Int. J. Pharm., 181, 173-179 (1999)
24. Park, K. M., Lee, M. K., Hwang, K. J., and Kim, C. K., Phospholipid-based microemulsions of flurbiprofen by the spontaneous emulsification process. Int. J. Pharm., 183, 145-154 (1999).
25. Racomska, A. and Dobrucki, R., The use of some ingredients for microemulsion preparation containing retinol and its esters. Int. J. Pharm., 196, 131-134 (2000).
26. Reed, K. W. and Yalkowsky, S. H., Lysis of human red blood cells in the presence of various cosolvents. J. Parenter. Sci. Technol., 39, 64-69 (1985).
27. Ruth, H. S., Attwood, D., Ktistis, G., and Taylor, C. J., Phase studies and particle size analysis of oil-in-water phospholipid microemulsions. Int. J. Pharm., 116, 253-261 (1995).
28. Ryoo, H. K., Park, C. W., Chi, S. C., and Park, E. S., Development of propofol-loaded microemulsion systems for parenteral delivery. Arch. Pharm. Res., 28, 1400-1404 (2005).
29. Singla, A. K., Garg, A., and Agarwal, D., Paclitaxel and its formulations. Int. J. Pharm., 235, 179-192 (2002).
30. Tricot, G., Joosten, E., Boogaerts, M.A., Vande Pitte, J., and Cauwenbergh, G., Ketoconazole vs. itraconazole for antifungal prophylaxis in patients with severe granulocytopenia: preliminary results of two nonrandomized studies. Rev. Infect. Dis., 9(Suppl 1), S94-99 (1987).
31. Trotta, M., Cavalli, R., Ugazio, E., and Gasco, M. R., Phase behaviour of microemulsion systems containing lecithin and lysolecithin as surfactants, Int. J. Pharm., 143, 67-73 (1996).
32. Van Cutsem, J., Van Gerven, F., and Janssen, P. A., Activity of orally, topically, and parenterally administered itraconazole in the treatment of superficial and deep mycoses: animal models. Rev. Infect. Dis., 9(Suppl 1), S15-32 (1987).
33. Volcheck, G. W. and Van Dellen, R. G., Anaphylaxis to intravenous cyclosporine and tolerance to oral cyclosporine: case report and review. Ann. Allergy Asthma Immunol., 80, 159-163 (1998).
34. Warisnoicharoen, W., Lansley, A. B., and Lawrence, M. J., Nonionic oil-in-water microemulsions: the effect of oil type on phase behaviour. Int. J. Pharm., 198, 7-27 (2000).
35. Warnock, D. W., Itraconazole and fluconazole: new drugs for deep fungal infection. J. Antimicrob. Chemother., 24, 275-277 (1989).
36. Working party of the British Society for Antimicrobial Chemotherapy, Chemoprophylaxis for candidosis and aspergillosis in neutropenia and transplantation: a review and recommendations. J. Antimicrob. Chemother., 32, 5-21 (1993).
37. Yi, Y., Yoon, H.J., Kim, B. O., Shim, M., Kim, S. O., Hwang, S. J., and Seo, M. H., A mixed polymeric micellar formulation of itraconazole: Characteristics, toxicity and pharmacokinetics. J. Control. Release, doi:10.1016/j.jconrel.2006.10.001 (2006).
38. Yoo, S. D., Kang, E. H., Jun, H., Shin, B. S., Lee, K. C., and Lee, K. H., Absorption, First- pass metabolism, and disposition of itraconazole in rats. Chem. Pharm. Bull., 48, 798-801 (2000).
39. Zhao, X., Chen, D., Gao, P., Ding, P., and Li, K., Synthesis of ibuprofen eugenol ester and its microemulsion formulation for parenteral delivery. Chem. Pharm. Bull., 53, 1246-1250 (2005).